Armitage James O
- SEC CIK
- 0001370087
No open-market purchases or sales filed in the past year.
Current role at each company
- CRDF Cardiff Oncology, Inc.Directoras of Jun 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Armitage James O as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2022 (view filing) | Sep 16 | 25 daysLate | Armitage James ODirector | PPurchase | +13.0K | $1.56 | +$20.3K | New position13.0K after |